New Search

If you are not happy with the results below please do another search

1122 search results for:

183

Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina

Cambrex announced the completion of its $38 million capacity expansion at its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina. This expansion doubles the facility’s manufacturing capacity, with new state-of-the-art analytical and chemical development laboratories, two new clinical manufacturing suites, and a small-scale commercial manufacturing operation with three work centers […]

185

Takara Bio Europe introduces HQ mRNA production enzymes

Takara Bio Europe (TBE) has introduced new High Quality (HQ) grade mRNA production enzymes “T7 RNA polymerase, HQ” and “Pyrophosphatase (inorganic), HQ” suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.  

188

Agilent receives European IVDR certification for companion diagnostic assay

Agilent Technologies has received a companion diagnostic (CDx) Class C IVDR certification for PD-L1 IHC 22C3 pharmDx, Code SK006. This CDx assay has previously been CE-IVD–marked for sales in the European Union and is now certified in accordance with the new EU Regulation for in vitro diagnostic medical devices (IVDR).